Obesity, Appetite Control & Diabetes
Obesity, Appetite Control & Diabetes(肥胖，食欲控制 & 糖尿病)
Obesity, Appetite Control & Diabetes
Satiety, appetite, and craving are CNS drives, whereas metabolism and energy utilization are peripheral endocrine actions.
Stephen M. Stahl, M.D., Ph.D. read more
Obesity, Appetite Control & Diabetes 相关产品(350)
- GC48184Tolbutamide-d9CAS: 1219794-57-6纯度: >99.00%
An internal standard for the quantification of tolbutamide
- GC48200Trelagliptin-13C-d3CAS: 2707203-34-5纯度: >99.00%
A neuropeptide with diverse biological activities
- GC48250Vildagliptin-d7CAS: 1133208-42-0纯度: >99.00%
An internal standard for the quantification of vildagliptin
- GC48744Gliclazide-d4CAS: 1185039-30-8纯度: >99.00%
An internal standard for the quantification of gliclazide
- GC49006Glycohyocholic Acid-d4CAS: 32747-08-3纯度: >99.00%
An internal standard for the quantification of glycohyocholic acid
- GC49008α-Muricholic Acid-d4纯度: >99.00% deuterated forms (d1-d4)
An internal standard for the quantification of α-muricholic acid
- GC49062Tiopronin-d3CAS: 1189700-74-0纯度: >99.00%
An internal standard for the quantification of tiopronin
- GC491693,8’-BiapigeninCAS: 101140-06-1纯度: >98.00%
A biflavonoid with diverse biological activities
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC48184 | Tolbutamide-d9 | 1219794-57-6 | >99.00% | |
An internal standard for the quantification of tolbutamide | ||||
| GC48196 | trans-Vaccenic Acid-d13 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48200 | Trelagliptin-13C-d3 | 2707203-34-5 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48250 | Vildagliptin-d7 | 1133208-42-0 | >99.00% | |
An internal standard for the quantification of vildagliptin | ||||
| GC48272 | ZLY032 | 2314465-67-1 | >98.00% | |
A dual FFAR1 and PPARδ agonist | ||||
| GC48328 | Obestatin (human) (trifluoroacetate salt) | - | >95.00% | |
A peptide hormone | ||||
| GC48360 | WKYMVm (trifluoroacetate salt) | - | >98.00% | |
A synthetic peptide agonist of FPR1 and FPR2 | ||||
| GC48418 | N-(2-Poc-ethyl)betulin amide | - | >95.00% | |
An alkyne derivative of betulin | ||||
| GC48449 | 28-(Poc-amino)betulin | - | >95.00% | |
An alkyne derivative of betulin | ||||
| GC48461 | rac-trans-4-hydroxy Glyburide | 23155-00-2 | >98.00% | |
An active metabolite of glyburide | ||||
| GC48521 | KRP 297 | 213252-19-8 | >98.00% | |
A dual agonist of PPARα and PPARγ | ||||
| GC48677 | Sulindac-d3 | - | >99.00% | |
An internal standard for the quantification of sulindac | ||||
| GC48710 | 11-Dehydrocorticosterone | 72-23-1 | >90.00% | |
An endogenous mineralocorticoid | ||||
| GC48744 | Gliclazide-d4 | 1185039-30-8 | >99.00% | |
An internal standard for the quantification of gliclazide | ||||
| GC49006 | Glycohyocholic Acid-d4 | 32747-08-3 | >99.00% | |
An internal standard for the quantification of glycohyocholic acid | ||||
| GC49008 | α-Muricholic Acid-d4 | - | >99.00% deuterated forms (d1-d4) | |
An internal standard for the quantification of α-muricholic acid | ||||
| GC49012 | Tauro-β-muricholic Acid-d4 (sodium salt) | - | >99.00% | |
tauro-β-muricholic acid 定量的内标 | ||||
| GC49024 | Palmitic Acid MaxSpec® Standard | 57-10-3 | >95.00% | |
A long-chain saturated fatty acid | ||||
| GC49062 | Tiopronin-d3 | 1189700-74-0 | >99.00% | |
An internal standard for the quantification of tiopronin | ||||
| GC49066 | (R)-Hydroxychloroquine (sulfate) | 2488706-20-1 | >95.00% | |
An isomer of hydroxychloroquine | ||||
| GC49067 | (S)-Hydroxychloroquine (sulfate) | 155204-09-4 | >95.00% | |
An isomer of hydroxychloroquine | ||||
| GC49110 | AICA Ribonucleotide | 3031-94-5 | >95.00% | |
An AMPK activator | ||||
| GC49146 | Colupulone | 468-27-9 | >95.00% | |
A β-acid with diverse biological activities | ||||
| GC49169 | 3,8’-Biapigenin | 101140-06-1 | >98.00% | |
A biflavonoid with diverse biological activities | ||||